Moderna stock touches 52-week low at $55.65 amid market shifts

Oct 17, 2024 · The stock's current price of $57.46 is trading near its 52-week low, representing only 32.78% of its 52-week high. This presents a potential opportunity for investors, especially …

78%
OFF

Moderna Stock Touches 52-week Low At $55.65 Amid Market Shifts

2 weeks from now

Oct 17, 2024 · The stock's current price of $57.46 is trading near its 52-week low, representing only 32.78% of its 52-week high. This presents a potential opportunity for investors, especially …

investing.com

$55.65
OFF

Moderna Stock Touches 52-week Low At $55.65 Amid Market Shifts

2 weeks from now

Oct 17, 2024 · Moderna (NASDAQ: MRNA) Inc. shares have reached a 52-week low, dipping to $55.65, as the biotechnology company known for its mRNA vaccines faces a challenging …

investing.com

17%
OFF

Moderna Stock Touches 52-week Low At $52.21 Amid Market Shifts

2 weeks from now

Nov 5, 2024 · The company's stock is currently trading near its 52-week low, with InvestingPro data showing a 57.17% price decline over the past six months. This steep drop reflects the …

investing.com

$55.65
OFF

Moderna Stock Touches 52-week Low At $55.65 Amid Market Shifts

2 weeks from now

Oct 17, 2024 · Moderna stock touches 52-week low at $55.65 amid market shifts

investing.com

$57.71
OFF

Moderna Stock Touches 52-week Low At $57.71 Amid Market Shifts

2 weeks from now

Oct 10, 2024 · In a challenging market environment, Moderna Inc. (NASDAQ: MRNA) stock has reached a 52-week low, dipping to $57.71.The biotechnology company, known for its mRNA …

investing.com

88%
OFF

Moderna Stock Touches 52-week Low At $57.71 Amid Market Shifts

2 weeks from now

Oct 10, 2024 · The company's shares are currently trading near their 52-week low, with InvestingPro data showing a significant price decline of 49.88% over the past three months. …

investing.com

53%
OFF

Moderna Stock Touches 52-week Low At $62.53 Amid Market Shifts

2 weeks from now

Oct 3, 2024 · The company's stock is indeed trading near its 52-week low, as highlighted in the article, with InvestingPro data showing a significant price decline of 45.53% over the past three …

investing.com

$57.71
OFF

Moderna Stock Hits 52-Week Low Of $57.71 Amid Market Shifts

2 weeks from now

In a challenging market landscape, Moderna Inc. has reached a 52-week low, with its stock dipping to $57.71. The biotechnology firm, recognized for its. In a challenging market …

marketbeatnow.com

$52.21
OFF

Moderna Stock Touches 52-week Low At $52.21 Amid Market Shifts

2 weeks from now

Nov 5, 2024 · In a challenging market environment, Moderna Inc . (BMV: MRNA) stock has reached a 52-week low, dipping to $52.21.The biotechnology company, known for its pivotal …

investing.com

$41.52
OFF

Moderna Stock Touches 52-week Low At $41.52 Amid Market …

2 weeks from now

Nov 14, 2024 · In a turbulent market environment, Moderna Inc . (BMV: MRNA) stock has recorded a new 52-week low, dipping to $41.52.The biotechnology company, known for its …

investing.com

$33.31
OFF

Moderna Stock Hits 52-week Low At $33.31 Amid Market Challenges

2 weeks from now

3 days ago · In a turbulent market environment, Moderna Inc . (BMV: MRNA) stock has tumbled to a 52-week low, touching down at $33.31. With a market capitalization of $16.26 billion, the …

investing.com

96%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why

2 weeks from now

Oct 14, 2024 · The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P …

nasdaq.com

53%
OFF

Moderna Stock Touches 52-week Low At $62.53 Amid Market Shifts

2 weeks from now

Oct 3, 2024 · The company's stock is indeed trading near its 52-week low, as highlighted in the article, with InvestingPro data showing a significant price decline of 45.53% over the past three …

investing.com

55%
OFF

Why Moderna (MRNA) Dipped More Than Broader Market Today

2 weeks from now

Oct 21, 2024 · The latest trading session saw Moderna (MRNA) ending at $53.80, denoting a -0.55% adjustment from its last day's close. The stock's performance was behind the S&P …

yahoo.com

FAQs about Moderna stock touches 52-week low at $55.65 amid market shifts Coupon?

What was the 52-week low for Moderna stock?

The low in the last 52 weeks of Moderna stock was 35.81. According to the current price, Moderna is 117.98% away from the 52-week low. What was the 52-week high for Moderna stock? The high in the last 52 weeks of Moderna stock was 170.36. According to the current price, Moderna is 24.80% away from the 52-week high. ...

How far is Moderna stock from the 52-week high?

The high in the last 52 weeks of Moderna stock was 170.36. According to the current price, Moderna is 24.80% away from the 52-week high. What are analysts forecasts for Moderna stock? The 38 analysts offering price forecasts for Moderna have a median target of 142.79, with a high estimate of 231.00 and a low estimate of 69.00. ...

How did Moderna’s stock perform over the last week?

Moderna (NASDAQ: MRNA) stock rose by about 4% over the last week to levels of around $113 per share. Here’s a quick rundown of the developments for the company over the last week. ...

What is the average Moderna stock price?

The average Moderna stock price for the last 52 weeks is 91.90. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. ...

How has Moderna impacted the medical sector?

Prior to today's trading, shares of the biotechnology company had lost 17.64% over the past month. This has lagged the Medical sector's loss of 3.03% and the S&P 500's gain of 4.46% in that time. Market participants will be closely following the financial results of Moderna in its upcoming release. ...

What are the Zacks consensus estimates for Moderna?

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$9.94 per share and a revenue of $3.2 billion, representing changes of +19.38% and -53.33%, respectively, from the prior year. Investors should also pay attention to any latest changes in analyst estimates for Moderna. ...